how much weight loss glp 1 What are GLP-1s? GLP-1 Agonists Weight Loss Drugs

Mercedez Hernandez walks through what patients should consider when weighing their options

These findings underscore the importance of careful monitoring to address these potential risks

Monitoring and follow-up should be arranged at 3 months initially to assess HbA1c response, tolerability, weight change, blood pressure, and renal function

Of the patients who took semaglutide and then developed NAION, those aged 40 to 64 (HR=3.31), who were female (HR=3.24), who were white (HR=2.34) or who had hypertension (HR=2.42) were more likely to be affected

Women of childbearing potential should use effective contraception while on treatment and discuss stopping the medication before planned conception